MOLLY MCELWEE: Open Payments
NPI 1649034851 · HOLMDEL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,222 in 58 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $694 · 2025 $1,222
Food & beverage: $1,142Education: $80
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $387 |
| Lundbeck LLC | 10 | $170 |
| Otsuka America Pharmaceutical, Inc. | 3 | $165 |
| ABBVIE INC. | 15 | $160 |
| Bausch Health US, LLC | 7 | $114 |
| Neurocrine BioSciences, Inc. | 4 | $74 |
| Sequel Med Tech, LLC | 1 | $63 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Eisai Inc. | 1 | $15 |
Products named: REXULTI, AUSTEDO XR, VRAYLAR, INGREZZA, WELLBUTRIN, TWIIST, Auvelity, APLENZIN.
Industry payments across NJ — which companies pay providers there.
